Shiyuan Bi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shiyuan Bi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jing Kong
Biliary Surgery (2nd General) Unit, Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
1 shared publication - Liwei Pang
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
1 shared publication - Shaojie Yang
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
1 shared publication - Shuo-Dong Wu
Department of Biliary and Vascular Surgery, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publication - Wanlin Dai
Innovation Institute of China Medical University
1 shared publication - Xiaolin Zhang
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
1 shared publication
Latest Publications
- Open Access
- 8 June 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah (7) , 2025-2036
Effectiveness and safety of central pancreatectomy in benign or low-grade malignant pancreatic body lesions: a systematic review and meta-analysis
Background: The best approach for treating benign or low-grade malignant lesions localized in the pancreatic neck or body remains debatable. Conventional pancreatoduodenectomy and distal pancreatectomy (DP) are associated with a risk of impairment of pancreatic function at long-term follow-up. With advances in technology and surgical skills, the use of central pancreatectomy (CP) has gradually increased. Objectives: To compare the safety, feasibility, and short-term and long-term clinical benefits of CP and DP in matched cases. Methods: The PubMed, MEDLINE, Web of Science, Cochrane, and EMBASE databases were systematically searched to identify studies published from database inception to February 2022 that compared CP and DP. This meta-analysis was performed using R software. Results: Twenty-six studies matched the selection criteria, including 774 CP and 1713 DP cases. CP was associated with significantly higher rates of operative time (PPPPP=0.0196), delayed gastric emptying (P=0.0096), hospital stay (PPPPP<0.0001) than DP. Conclusions: CP should be considered as an alternative to DP in selected cases such as without pancreatic disease, length of the residual distal pancreas ≥5 cm, branch-duct IPMNs, and a low risk of POPF after adequate evaluation.
- 8 June 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah (7) , 2025-2036
Open AccessEffectiveness and safety of central pancreatectomy in benign or low-grade malignant pancreatic body lesions: a systematic review and meta-analysis
Background: The best approach for treating benign or low-grade malignant lesions localized in the pancreatic neck or body remains debatable. Conventional pancreatoduodenectomy and distal pancreatectomy (DP) are associated with a risk of impairment of pancreatic function at long-term follow-up. With advances in technology and surgical skills, the use of central pancreatectomy (CP) has gradually increased. Objectives: To compare the safety, feasibility, and short-term and long-term clinical benefits of CP and DP in matched cases. Methods: The PubMed, MEDLINE, Web of Science, Cochrane, and EMBASE databases were systematically searched to identify studies published from database inception to February 2022 that compared CP and DP. This meta-analysis was performed using R software. Results: Twenty-six studies matched the selection criteria, including 774 CP and 1713 DP cases. CP was associated with significantly higher rates of operative time (PPPPP=0.0196), delayed gastric emptying (P=0.0096), hospital stay (PPPPP<0.0001) than DP. Conclusions: CP should be considered as an alternative to DP in selected cases such as without pancreatic disease, length of the residual distal pancreas ≥5 cm, branch-duct IPMNs, and a low risk of POPF after adequate evaluation.